Nengrui Yang

Papers

Total Citations

H-Index

About

Nengrui Yang is a rising surgical oncologist whose research focuses on advancing minimally invasive treatments for urological cancers, particularly penile cancer. His major contribution lies in pioneering comparative studies of antegrade robotic-assisted inguinal lymphadenectomy (RAIL) versus laparoscopic inguinal lymphadenectomy (LIL), a critical area for reducing morbidity in penile cancer management. His most cited work, published in 2023, has already garnered 7 citations, highlighting its immediate impact in guiding clinical decisions between these two techniques. By systematically evaluating outcomes such as operative time, lymph node yield, and complications, Yang’s research provides evidence-based insights that help surgeons select the optimal minimally invasive approach for inguinal lymph node dissection. His 2022 study, with 3 citations, further solidifies his expertise in this niche. Yang’s work is notable for addressing a key gap in urological oncology—balancing oncological efficacy with reduced surgical trauma. As a young investigator, his contributions are shaping the future of penile cancer surgery, offering patients less invasive options without compromising outcomes. His research is essential reading for surgeons and trainees seeking to understand the evolving landscape of robotic and laparoscopic techniques in urologic oncology.